Karachi: Highnoon Laboratories Limited has released details regarding recent transactions executed by its director, Ms. Tehmina Saeed Chaudhury, in compliance with the Pakistan Stock Exchange (PSX) regulations. The disclosure, dated April 1, 2026, outlines three separate transactions carried out in March 2026.

According to the disclosed information, Ms. Chaudhury sold a total of 13,495 shares at a rate of 918 per share on March 3, 2026. Subsequently, she made two purchases, acquiring 5,000 shares at 756 per share on March 9, 2026, and another 5,000 shares at 884 per share on March 16, 2026. All transactions were executed in the Central Depository Company (CDC) ready market.

According to information available from the Pakistan Stock Exchange (PSX), these transactions will be reviewed in the upcoming board meeting. The board will consider any potential non-compliances as stipulated under clause No. 5.6.1(d) of the PSX Regulations, ensuring that all relevant procedures and requirements are duly followed.

These developments come as part of regular compliance and disclosure practices mandated by the PSX, aimed at maintaining transparency in market operations. The designation of the market category for these transactions falls under the “ready market” category.